There have been several studies done to determine the effects of Tradjenta for type 2 diabetes.
Tradjenta and Hemoglobin A1c
Hemoglobin A1c (HbA1c) is a test used to measure long-term blood sugar control. For people without diabetes, HbA1c results are usually less than 6 percent, while people with diabetes usually have higher results. In one study, people taking Tradjenta lowered their HbA1c by 0.4 percent on average, while people not taking this drug increased their HbA1c by 0.3 percent.
Studies have shown that the higher the HbA1c, the greater the chance for developing long-term problems related to diabetes. This includes problems such as heart disease, diabetic retinopathy, diabetic neuropathy, and diabetic nephropathy. By controlling blood sugar levels with Tradjenta, it may be possible to decrease the chances for developing these diabetes complications. However, studies have not yet shown that Tradjenta, or any other diabetes medication, prevents these complications.
Tradjenta and Blood Sugar Levels
In studies, Tradjenta lowered fasting blood sugar levels by 8.5 mg/dL on average. Tradjenta also lowered 2-hour postprandial blood sugar levels (blood sugar levels 2 hours after a meal) by 33.5 mg/dL on average.
Some general considerations to keep in mind during treatment with Tradjenta include the following:
- Tradjenta comes in tablet form. It is taken by mouth once a day.
- This medication can be taken with or without food.
- It does not matter what time of day you take Tradjenta; however, try to take it at the same time every day.
- For the medication to work properly, it must be taken as prescribed.